MARK2 Activators
Serine/threonine-protein kinase MARK2 Activators are a class of compounds that can enhance the functionality of MARK2 through specific biochemical or cellular pathways that MARK2 is involved in. These compounds do not activate MARK2 directly, but rather impact specific signaling pathways or biological processes, resulting in an indirect enhancement of MARK2 activity. These compounds represent a broad range of chemical structures and mechanisms of action. They include proteasome inhibitor MG132, tyrosine kinase inhibitor Genistein, and mTOR inhibitor Rapamycin. These compounds function by modulating the activity of key enzymes or proteins within specific cellular pathways, thus indirectly influencing MARK2 functionality. Other compounds like Trichostatin A and 5-Azacitidine affect gene expression through histone deacetylation and DNA methylation respectively. By impacting these processes, they could influence MARK2 function.
Furthermore, there are compounds like SB203580, LY294002, PD98059, U0126, and ZM 336372, which target various kinases involved in cellular signaling pathways. MARK2 plays a role in several signaling pathways, and modulation of these pathways could influence MARK2 activity indirectly. Lastly, Y-27632, a ROCK inhibitor, could affect MARK2 function by impacting cellular adhesion and motility processes. By targeting different aspects of cellular processes and signaling pathways, these compounds collectively provide a multifaceted approach to indirectly enhancing the functionality of MARK2. However, it is important to note that the precise mechanisms through which these compounds might impact MARK2 activity remain to be fully elucidated.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 inhibits proteasomes, which prevents the degradation of ubiquitinated proteins. MARK2 is known to interact with several proteins that could be stabilized by MG132, indirectly enhancing the functional activity of MARK2. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase (HDAC) inhibitor. HDACs repress gene expression, and their inhibition can affect transcriptional regulation, where MARK2 is known to play a role. This way, Trichostatin A can indirectly enhance the functionality of MARK2. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacitidine is a DNA methyltransferase inhibitor. It alters gene expression by affecting DNA methylation status. Given MARK2's role in gene expression, 5-Azacitidine could indirectly enhance the activity of MARK2. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits the kinase activity of p38 MAPK, a protein involved in cell cycle control. By influencing cell cycle control, SB203580 could indirectly modulate the activity of MARK2. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, and PI3K signaling impacts cell proliferation. As MARK2 is involved in cell cycle and proliferation, LY294002 could indirectly influence MARK2 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is part of the ERK/MAPK pathway. Given MARK2's role in cell signaling, PD98059's impact on the ERK/MAPK pathway could indirectly influence MARK2 activity. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
H89 is a Protein kinase A (PKA) inhibitor. PKA is involved in numerous cellular processes including cell proliferation and differentiation, where MARK2 is also known to play a role. H89 dihydrochloride could indirectly enhance the functionality of MARK2 through this pathway. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that impacts signaling pathways controlling cell growth and proliferation. As MARK2 has roles in these processes, Genistein could indirectly influence MARK2 activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor. The Rho/ROCK pathway is involved in cell adhesion and motility. Given MARK2's role in cell adhesion, Y-27632 could indirectly enhance the functional activity of MARK2. | ||||||